Digby J W, Wehner S
J Int Med Res. 1976;4(6):427-31. doi: 10.1177/030006057600400608.
Twenty-three patients with rheumatoid arthritis participated in a double-blind crossover investigation of ketoprofen (Orudis) and indomethacin. Ratings which assessed the degree of joint involvement showed consistently greater improvement with Orudis, and side-effects occurred with less frequency. The majority of patients expressed a definite preference for Orudis.
23名类风湿性关节炎患者参与了酮洛芬(奥鲁地)和吲哚美辛的双盲交叉试验。评估关节受累程度的评分显示,使用奥鲁地的患者改善情况始终更佳,且副作用出现频率更低。大多数患者明确表示更喜欢奥鲁地。